TY - JOUR
T1 - Exercise, radial pressure waves, and photobiomodulation for management of non-insertional Achilles tendinopathy in runners
T2 - a three-arm non-blinded randomised control trial
AU - Tenforde, Adam S.
AU - Pham, Linh
AU - Gaudette, Logan Walter
AU - Funk, Margaret M.
AU - Vogel, Katie EL
AU - Bruneau, Michelle M.
AU - Yuan, Xiaoning
AU - Schroeder, Jeremy D.
AU - Isaacson, Brad
AU - Hagar, Nelson
AU - Metzger, Elizabeth
AU - Nolan, David C.
AU - Tam, Joshua
AU - Silbernagel, Karin Gravare
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2025/10/5
Y1 - 2025/10/5
N2 - Objectives Non-insertional Achilles tendinopathy (AT) is a common running injury. Exercise loading programme (EXER) is the primary treatment. Other options include radial pressure wave (RPW, commonly referred to as shockwave) and photobiomodulation therapy (PBMT). We hypothesised that EXER+RPWand EXER+RPW+PBMT would result in greater reduction in symptoms measured using the eight-item Victorian Institute of Sports Assessment-Achilles (VISA-A) and greater improvement in functional outcomes compared with EXER. A secondary aim was to explore outcomes using elective treatment for three additional months. Methods Runners with AT and symptoms exceeding 3 months were randomised to EXER, EXER+RPW or EXER+RPW+PBMT. RPW was delivered once weekly for three treatments. Those assigned to receive PBMT additionally received treatment two times a week for 3weeks. VISA-A, University of Wisconsin Running Injury and Recovery Index and Patient-Reported Outcomes Measurement Information System 29-item were obtained at baseline and intervals over 3months. Afterwards, runners could elect to receive a different treatment for three additional months. Results Forty-six runners enrolled (24 males, 22 females; average age±SD:40±12 years). Runners assigned EXER+RPW had a greater improvement than EXER at 3months in VISA-A (mean 33 vs 18 points, p=0.023; 95% CI 28.4 to 2.4), and no differences were detected between EXER+RPW+PBMT and EXER (25 vs 18 points, p=0.12; 95% CI 25.9 to –10.8). There were greater improvements in running index measures, pain interference and social roles in EXER+RPW compared with EXER. VISA-A increased over 3month crossover to EXER+RPWand EXER+RPW+PBMT (11 points, both p<0.05 compared with EXER). Discussion Combined EXER and RPW had the largest measured reduction in symptoms at 3 months. However, all groups met clinical improvement, highlighting the importance of EXER. Larger studies in other physically active populations may clarify clinical benefits of each treatment.
AB - Objectives Non-insertional Achilles tendinopathy (AT) is a common running injury. Exercise loading programme (EXER) is the primary treatment. Other options include radial pressure wave (RPW, commonly referred to as shockwave) and photobiomodulation therapy (PBMT). We hypothesised that EXER+RPWand EXER+RPW+PBMT would result in greater reduction in symptoms measured using the eight-item Victorian Institute of Sports Assessment-Achilles (VISA-A) and greater improvement in functional outcomes compared with EXER. A secondary aim was to explore outcomes using elective treatment for three additional months. Methods Runners with AT and symptoms exceeding 3 months were randomised to EXER, EXER+RPW or EXER+RPW+PBMT. RPW was delivered once weekly for three treatments. Those assigned to receive PBMT additionally received treatment two times a week for 3weeks. VISA-A, University of Wisconsin Running Injury and Recovery Index and Patient-Reported Outcomes Measurement Information System 29-item were obtained at baseline and intervals over 3months. Afterwards, runners could elect to receive a different treatment for three additional months. Results Forty-six runners enrolled (24 males, 22 females; average age±SD:40±12 years). Runners assigned EXER+RPW had a greater improvement than EXER at 3months in VISA-A (mean 33 vs 18 points, p=0.023; 95% CI 28.4 to 2.4), and no differences were detected between EXER+RPW+PBMT and EXER (25 vs 18 points, p=0.12; 95% CI 25.9 to –10.8). There were greater improvements in running index measures, pain interference and social roles in EXER+RPW compared with EXER. VISA-A increased over 3month crossover to EXER+RPWand EXER+RPW+PBMT (11 points, both p<0.05 compared with EXER). Discussion Combined EXER and RPW had the largest measured reduction in symptoms at 3 months. However, all groups met clinical improvement, highlighting the importance of EXER. Larger studies in other physically active populations may clarify clinical benefits of each treatment.
KW - Achilles
KW - Shockwave
KW - Sport
KW - Tendon
UR - http://www.scopus.com/inward/record.url?scp=105019699685&partnerID=8YFLogxK
U2 - 10.1136/bmjsem-2024-002442
DO - 10.1136/bmjsem-2024-002442
M3 - Article
AN - SCOPUS:105019699685
SN - 2055-7647
VL - 11
JO - BMJ Open Sport and Exercise Medicine
JF - BMJ Open Sport and Exercise Medicine
IS - 4
M1 - e002442
ER -